Cargando…
CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
Animal models and clinical studies have linked the innate and adaptive immune system to the pathology of Parkinson’s disease (PD). Despite such progress, the specific immune responses that influence disease progression have eluded investigators. Herein, we assessed relationships between T cell pheno...
Autores principales: | Saunders, Jessica A. Hutter, Estes, Katherine A., Kosloski, Lisa M., Allen, Heather E., Dempsey, Kathryn M., Torres-Russotto, Diego R., Meza, Jane L., Santamaria, Pamela M., Bertoni, John M., Murman, Daniel L., Ali, Hesham H., Standaert, David G., Mosley, R. Lee, Gendelman, Howard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515774/ https://www.ncbi.nlm.nih.gov/pubmed/23054369 http://dx.doi.org/10.1007/s11481-012-9402-z |
Ejemplares similares
-
Neuromagnetic Evidence of Abnormal Movement-Related Beta Desynchronization in Parkinson's Disease
por: Heinrichs-Graham, Elizabeth, et al.
Publicado: (2014) -
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders
por: Anderson, Kristi M, et al.
Publicado: (2014) -
An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
por: Olson, Katherine E., et al.
Publicado: (2023) -
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
por: Gendelman, Howard E., et al.
Publicado: (2017) -
Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson’s disease
por: Schutt, Charles R., et al.
Publicado: (2018)